Cargando…
Guiding Drug Repositioning for Cancers Based on Drug Similarity Networks
Drug repositioning aims to discover novel clinical benefits of existing drugs, is an effective way to develop drugs for complex diseases such as cancer and may facilitate the process of traditional drug development. Meanwhile, network-based computational biology approaches, which allow the integrati...
Autores principales: | Qin, Shimei, Li, Wan, Yu, Hongzheng, Xu, Manyi, Li, Chao, Fu, Lei, Sun, Shibin, He, Yuehan, Lv, Junjie, He, Weiming, Chen, Lina |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9917231/ https://www.ncbi.nlm.nih.gov/pubmed/36768566 http://dx.doi.org/10.3390/ijms24032244 |
Ejemplares similares
-
Integrating Expression Data-Based Deep Neural Network Models with Biological Networks to Identify Regulatory Modules for Lung Adenocarcinoma
por: Fu, Lei, et al.
Publicado: (2022) -
Prediction of Drug-Target Interactions for Drug Repositioning Only Based on Genomic Expression Similarity
por: Wang, Kejian, et al.
Publicado: (2013) -
Leader gene identification for digestive system cancers based on human subcellular location and cancer-related characteristics in protein–protein interaction networks
por: Chen, Hongwei, et al.
Publicado: (2022) -
Identification of polycystic ovary syndrome potential drug targets based on pathobiological similarity in the protein-protein interaction network
por: Huang, Hao, et al.
Publicado: (2016) -
Correction: Prediction of Drug-Target Interactions for Drug Repositioning Only Based on Genomic Expression Similarity
por: Wang, Kejian, et al.
Publicado: (2013)